CONMED Income from Continuous Operations 2010-2024 | CNMD
CONMED income from continuous operations from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
CONMED Annual Income from Continuous Operations (Millions of US $) |
2023 |
$64 |
2022 |
$-81 |
2021 |
$63 |
2020 |
$10 |
2019 |
$29 |
2018 |
$41 |
2017 |
$55 |
2016 |
$15 |
2015 |
$30 |
2014 |
$32 |
2013 |
$36 |
2012 |
$40 |
2011 |
$1 |
2010 |
$30 |
2009 |
$12 |
CONMED Quarterly Income from Continuous Operations (Millions of US $) |
2024-09-30 |
$49 |
2024-06-30 |
$30 |
2024-03-31 |
$20 |
2023-12-31 |
$33 |
2023-09-30 |
$16 |
2023-06-30 |
$14 |
2023-03-31 |
$2 |
2022-12-31 |
$27 |
2022-09-30 |
$46 |
2022-06-30 |
$-168 |
2022-03-31 |
$15 |
2021-12-31 |
$24 |
2021-09-30 |
$15 |
2021-06-30 |
$13 |
2021-03-31 |
$10 |
2020-12-31 |
$24 |
2020-09-30 |
$7 |
2020-06-30 |
$-27 |
2020-03-31 |
$6 |
2019-12-31 |
$15 |
2019-09-30 |
$7 |
2019-06-30 |
$6 |
2019-03-31 |
$1 |
2018-12-31 |
$16 |
2018-09-30 |
$6 |
2018-06-30 |
$9 |
2018-03-31 |
$11 |
2017-12-31 |
$47 |
2017-09-30 |
$7 |
2017-06-30 |
$6 |
2017-03-31 |
$-5 |
2016-12-31 |
$7 |
2016-09-30 |
$7 |
2016-06-30 |
$3 |
2016-03-31 |
$-2 |
2015-12-31 |
$8 |
2015-09-30 |
$9 |
2015-06-30 |
$7 |
2015-03-31 |
$6 |
2014-12-31 |
$11 |
2014-09-30 |
$2 |
2014-06-30 |
$10 |
2014-03-31 |
$9 |
2013-12-31 |
$10 |
2013-09-30 |
$6 |
2013-06-30 |
$10 |
2013-03-31 |
$10 |
2012-12-31 |
$11 |
2012-09-30 |
$9 |
2012-06-30 |
$10 |
2012-03-31 |
$10 |
2011-12-31 |
$-25 |
2011-09-30 |
$8 |
2011-06-30 |
$9 |
2011-03-31 |
$9 |
2010-12-31 |
$7 |
2010-09-30 |
$9 |
2010-06-30 |
$7 |
2010-03-31 |
$7 |
2009-12-31 |
$5 |
2009-09-30 |
$1 |
2009-06-30 |
$1 |
2009-03-31 |
$4 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$2.216B |
$1.245B |
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
|